Etoricoxib
SIAL/32097 - VETRANAL®, analytical standard
Synonym: 5-
CAS Number: 202409-33-4
Empirical Formula (Hill Notation): C18H15ClN2O2S
Molecular Weight: 358.84
MDL Number: MFCD06797512
Linear Formula: C18H15ClN2O2S
Product Type: Chemical
| application(s) | forensics and toxicology pharmaceutical (small molecule) veterinary |
| format | neat |
| grade | analytical standard |
| InChI | 1S/C18H15ClN2O2S/c1-12-3- |
| InChI key | MNJVRJDLRVPLFE-UHFFFAOYSA |
| product line | VETRANAL® |
| Quality Level | 100 ![]() |
| shelf life | limited shelf life, expiry date on the label |
| SMILES string | CC1=NC=C(C2=C(C3=CC=C(S(C |
| storage temp. | 2-8°C |
| technique(s) | gas chromatography (GC): suitable |
| HPLC: suitable |
| Application: | Etoricoxib may have been used as reference standard in liquid chromatography-tandem mass spectrometry method with atmospheric pressure chemical ionization (LC-APCI/MS/MS) method for determination of etoricoxib from human plasma. |
| Application: | Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support. |
| General description: | Etoricoxib is a non-steroidal cyclooxygenase-2 (COX-2) selective anti-inflammatory drug mostly used to treat patients suffering from osteoarthritis and rheumatoid arthritis. |
| Legal Information: | VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H302 - H310 |
| Precautionary statements | P262 - P264 - P270 - P280 - P301 + P312 - P302 + P352 + P310 |
| Hazard Codes | T |
| Risk Statements | 22-24 |
| Safety Statements | 36/37-45 |
| RIDADR | UN 2811 6.1 / PGII |
| WGK Germany | WGK 3 |
| Storage Temp. | 2-8°C |
| UNSPSC | 41116107 |


